Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $16
Benzinga Newsdesk 48 minutes ago
Analyst RatingsNewsPrice Target
Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $15 to $16.
Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $15 to $16.